ArticleCognitive and behavioral practice2026
Development and Pilot Testing of Transdiagnostic Exposure Therapy/Behavioral Activation for Autistic Adolescents With Internalizing Disorders.
Article in Cognitive and behavioral practice, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
10 authors.
Funding
Abstract
Internalizing disorders disproportionately affect autistic adolescents, though limited research has focused on tailoring therapy for this population. The purposes of this paper were (1) to describe the development of a transdiagnostic exposure therapy/behavioral activation intervention for autistic adolescents with internalizing disorders, and (2) to present a pilot test of feasibility, acceptability, and efficacy of the intervention. The development of this therapy is described in detail, which prioritized the following domains: (1) building on the existing evidence base of exposure-based cognitive behavioral therapy for autistic youth with anxiety disorders, (2) involving caregivers considerably, (3) incorporating autism-specific considerations into case conceptualization and treatment planning, (4) using a neurodiversity-affirming lens, (5) considering changes in therapy delivery for autistic adolescents, and (6) providing a conceptualization-driven, flexible, transdiagnostic framework to therapy. This adapted, exposure-therapy/behavioral activation approach was pilot tested with 14 adolescent-caregiver dyads, and showed strong acceptability and feasibility based on qualitative and quantitative data. The treatment response rate was 78% (11/14; based on the Clinical Global Impression-Improvement scale), and the primary diagnosis remission rate was 57% at the posttreatment assessment (8/14; based on the absence of the primary diagnosis assessed at baseline with a structured diagnostic interview), which benchmarks well on similar treatments that have been published in this literature among nonautistic youth. These pilot data provide a strong justification for a follow-up randomized trial testing efficacy and mechanisms.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.